Noninfective drug-related pneumonitis (DRP) is a well-known adverse effect of several drugs: clinical manifestations have mostly an acute/subacute onset and vary from mild to life-threatening. Several DRP cases have been described in patients receiving anti-tumor necrosis factor α, rituximab, and tocilizumab. To date, only 4 reports of vedolizumab-related pneumonitis have been presented..
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cgh.2021.08.041 | DOI Listing |
Publication Analysis
Top Keywords
drug-related pneumonitis
8
patients receiving
8
pneumonitis patients
4
receiving vedolizumab
4
vedolizumab therapy
4
therapy inflammatory
4
inflammatory bowel
4
bowel disease
4
disease noninfective
4
noninfective drug-related
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!